CN104873785B - 一种用于慢性宫颈炎电圈切除术后康复的中药制剂 - Google Patents
一种用于慢性宫颈炎电圈切除术后康复的中药制剂 Download PDFInfo
- Publication number
- CN104873785B CN104873785B CN201510326049.0A CN201510326049A CN104873785B CN 104873785 B CN104873785 B CN 104873785B CN 201510326049 A CN201510326049 A CN 201510326049A CN 104873785 B CN104873785 B CN 104873785B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine preparation
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 23
- 206010008323 cervicitis Diseases 0.000 title claims abstract description 16
- 201000003988 chronic cervicitis Diseases 0.000 title claims abstract description 15
- 239000009636 Huang Qi Substances 0.000 claims abstract description 17
- 241001264480 Lycopodiastrum casuarinoides Species 0.000 claims abstract description 17
- 239000002023 wood Substances 0.000 claims abstract description 17
- 241001061906 Caragana Species 0.000 claims abstract description 16
- 241001596270 Aizoon Species 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 239000012567 medical material Substances 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 15
- 238000009835 boiling Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000002386 leaching Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- -1 filter Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000003143 Panax notoginseng Nutrition 0.000 claims 2
- 241000180649 Panax notoginseng Species 0.000 claims 2
- 239000008280 blood Substances 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 29
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 12
- 230000023597 hemostasis Effects 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 4
- 238000001816 cooling Methods 0.000 abstract description 4
- 230000036407 pain Effects 0.000 abstract description 4
- 230000008961 swelling Effects 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 206010058046 Post procedural complication Diseases 0.000 abstract description 2
- 208000035965 Postoperative Complications Diseases 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- 208000032843 Hemorrhage Diseases 0.000 description 16
- 230000002980 postoperative effect Effects 0.000 description 14
- 230000000740 bleeding effect Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000003679 cervix uteri Anatomy 0.000 description 8
- 230000003628 erosive effect Effects 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 230000035619 diuresis Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- 206010046788 Uterine haemorrhage Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 239000003292 glue Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000036592 analgesia Effects 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 210000003756 cervix mucus Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000288027 Chrysolophus pictus Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010071229 Procedural haemorrhage Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000003505 cervical polyp Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 201000010380 endocervicitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007119 pathological manifestation Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000007560 sedimentation technique Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510326049.0A CN104873785B8 (zh) | 2015-06-13 | 2015-06-13 | 一种用于慢性宫颈炎电圈切除术后康复的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510326049.0A CN104873785B8 (zh) | 2015-06-13 | 2015-06-13 | 一种用于慢性宫颈炎电圈切除术后康复的中药制剂 |
Publications (3)
Publication Number | Publication Date |
---|---|
CN104873785A CN104873785A (zh) | 2015-09-02 |
CN104873785B true CN104873785B (zh) | 2016-08-17 |
CN104873785B8 CN104873785B8 (zh) | 2016-10-12 |
Family
ID=53941640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510326049.0A Expired - Fee Related CN104873785B8 (zh) | 2015-06-13 | 2015-06-13 | 一种用于慢性宫颈炎电圈切除术后康复的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104873785B8 (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225158A (zh) * | 2011-06-07 | 2011-10-26 | 李洁 | 一种治疗妇科急性宫颈炎的中药宫炎散 |
CN102335394A (zh) * | 2011-10-11 | 2012-02-01 | 陕西东泰制药有限公司 | 一种用于治疗宫颈糜烂的中药组合物及其制备方法 |
-
2015
- 2015-06-13 CN CN201510326049.0A patent/CN104873785B8/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225158A (zh) * | 2011-06-07 | 2011-10-26 | 李洁 | 一种治疗妇科急性宫颈炎的中药宫炎散 |
CN102335394A (zh) * | 2011-10-11 | 2012-02-01 | 陕西东泰制药有限公司 | 一种用于治疗宫颈糜烂的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104873785B8 (zh) | 2016-10-12 |
CN104873785A (zh) | 2015-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860978B (zh) | 一种治疗褥疮的中药制剂及其制备方法 | |
CN104274741A (zh) | 一种治疗妇科病的药物组合物及药用卫生巾 | |
CN103656382A (zh) | 一种治疗痔疮的中药汤剂 | |
CN103432270B (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN103071096B (zh) | 用于治疗老年性阴道炎的外用制剂及其制备方法 | |
CN102552665B (zh) | 一种用于治疗妇科疾病的外用中药组合物 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN104225490A (zh) | 一种治疗胆囊炎的中药 | |
CN103908639A (zh) | 一种治疗湿疹的外用洗剂 | |
CN104873785B (zh) | 一种用于慢性宫颈炎电圈切除术后康复的中药制剂 | |
CN100333779C (zh) | 一种治疗阴道炎宫颈炎的中药制剂 | |
CN100563694C (zh) | 一种外用治疗肛裂的中药组合物 | |
CN105106846B (zh) | 治疗子宫腺肌症的中药制剂配方 | |
CN104491670A (zh) | 一种治疗慢性盆腔炎的中药组合物 | |
CN104288518A (zh) | 一种治疗宫颈炎的中药组合物 | |
CN104367946A (zh) | 一种治疗慢性子宫内膜炎的中药栓剂及其制备方法 | |
CN102670858B (zh) | 一种治疗炎性外痔的洗剂 | |
CN103520638B (zh) | 一种治疗前列腺肥大症的中药复方组合物及其制备方法及其应用 | |
CN103721191A (zh) | 一种治疗妇女慢性盆腔炎的中药灌肠剂及其制备方法 | |
CN102949623B (zh) | 治疗输卵管积水的药物 | |
CN107334941A (zh) | 一种治疗慢性盆腔炎的中药及其制备方法 | |
CN105535674A (zh) | 用于治疗慢性宫颈炎的药物 | |
CN105106551A (zh) | 一种用于治疗肾囊肿的药物及制备方法 | |
CN104436054A (zh) | 一种治疗直肠癌的中药 | |
CN111329923A (zh) | 一种治疗痔疮的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Shi Peiqing Inventor before: Request for anonymity |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160801 Address after: 276600 Junan County People's Hospital, 156 Tianqiao Road, Junan, Shandong, Linyi Patentee after: Shi Peiqing Address before: 1 residential building, No. 443 Changjiang East Road, Huangdao District, Shandong, China, 1708, China, 266520 Patentee before: QINGDAO CHENDA BIOLOGICAL SCIENCE & TECHNOLOGY Co.,Ltd. |
|
C53 | Correction of patent of invention or patent application | ||
CI01 | Publication of corrected invention patent application |
Correction item: Patentee|Address|Inventor Correct: Shi Peiqing|276600 Junan County People's Hospital, 156 Tianqiao Road, Junan, Shandong, Linyi|Shi Peiqing False: QINGDAO CHENDA BIOLOGICAL SCIENCE & TECHNOLOGY Co.,Ltd.|1 residential building, No. 443 Changjiang East Road, Huangdao District, Shandong, China, 1708, China, 266520|The inventor has waived the right to be mentioned Number: 33 Volume: 32 |
|
CI03 | Correction of invention patent |
Correction item: Patentee|Address|Inventor Correct: Shi Peiqing|276600 Junan County People's Hospital, 156 Tianqiao Road, Junan, Shandong, Linyi|Shi Peiqing False: QINGDAO CHENDA BIOLOGICAL SCIENCE & TECHNOLOGY Co.,Ltd.|1 residential building, No. 443 Changjiang East Road, Huangdao District, Shandong, China, 1708, China, 266520|The inventor has waived the right to be mentioned Number: 33 Page: The title page Volume: 32 |
|
ERR | Gazette correction | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171211 Address after: 046011 North One Ring Road No. 9, Changzhi City, Shanxi Patentee after: CHANGZHI WUT ENGINEERING TECHNOLOGY Research Institute Address before: 276600 Junan County People's Hospital, 156 Tianqiao Road, Junan, Shandong, Linyi Patentee before: Shi Peiqing |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 |